VERONICA TIBURCIO-ESPINOZA: Open Payments
NPI 1295983625 · WILSONVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,273 in 46 payments from 12 companies in 2025. Trend: 2023 $758 · 2024 $1,628 · 2025 $1,273
Food & beverage: $1,273
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $601 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Lilly USA, LLC | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Amgen Inc. | 4 | $82 |
| SANOFI-AVENTIS U.S. LLC | 3 | $69 |
| PFIZER INC. | 2 | $58 |
| ARGENX US, INC. | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Exact Sciences Corporation | 2 | $32 |
Products named: Ozempic, Wegovy, FARXIGA, REXULTI, TZIELD, JARDIANCE, PREVNAR 20, OTEZLA.
Industry payments across OR — which companies pay providers there.
